Wells Fargo & Company Anixa Biosciences Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 8,500 shares of ANIX stock, worth $29,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,500

Previous 748 1036.36%

Holding current value

$29,325

Previous $2,000 800.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.21 - $3.35 $17,131 - $25,969	7,752 Added 1036.36%	8,500 $18,000
Q1 2024 May 10, 2024	BUY	$3.08 - $5.02 $27 - $45	9 Added 1.22%	748 $2,000
Q4 2023 Feb 09, 2024	BUY	$2.85 - $4.19 $37 - $54	13 Added 1.79%	739 $2,000
Q3 2023 Nov 13, 2023	BUY	$2.97 - $3.87 $8 - $11	3 Added 0.41%	726 $2,000
Q2 2023 Aug 15, 2023	BUY	$3.0 - $5.97 $27 - $53	9 Added 1.26%	723 $2,000
Q1 2023 May 12, 2023	SELL	$3.86 - $5.0 $3,840 - $4,975	-995 Reduced 58.22%	714 $3,000
Q4 2022 Feb 13, 2023	BUY	$3.78 - $5.81 $3,806 - $5,850	1,007 Added 143.45%	1,709 $7,000
Q2 2022 Aug 12, 2022	BUY	$2.55 - $4.1 $43 - $69	17 Added 2.48%	702 $3,000
Q1 2022 May 16, 2022	BUY	$2.5 - $3.42 $2 - $3	1 Added 0.15%	685 $2,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $15,842 - $30,255	-5,501 Reduced 88.94%	684 $2,000
Q3 2021 Nov 15, 2021	SELL	$3.57 - $5.6 $17 - $28	-5 Reduced 0.08%	6,185 $30,000
Q2 2021 Aug 16, 2021	BUY	$3.46 - $4.92 $107 - $152	31 Added 0.5%	6,190 $24,000
Q1 2021 May 13, 2021	BUY	$3.27 - $7.14 $16,392 - $35,792	5,013 Added 437.43%	6,159 $29,000
Q4 2020 Feb 09, 2021	SELL	$1.94 - $3.19 $11,717 - $19,267	-6,040 Reduced 84.05%	1,146 $3,000
Q3 2020 Nov 05, 2020	SELL	$1.79 - $3.3 $1,392 - $2,567	-778 Reduced 9.77%	7,186 $17,000
Q2 2020 Aug 13, 2020	SELL	$1.53 - $3.06 $182 - $364	-119 Reduced 1.47%	7,964 $24,000
Q1 2020 May 14, 2020	BUY	$1.35 - $4.06 $10,912 - $32,816	8,083 New	8,083 $13,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.56M

Call Options Held

Put Options Held

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $106M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Anixa Biosciences Inc Transaction History